Aortic Dissection Medication
- Author: Mary C Mancini, MD, PhD; Chief Editor: John Geibel, MD, DSc, MA more...
Medication Summary
Initial therapeutic goals include the elimination of pain and the reduction of systolic blood pressure to 100-120 mm Hg or to the lowest level commensurate with adequate vital organ (ie, cardiac, cerebral, renal) perfusion. Whether systolic hypertension or pain is present, beta-blockers are used to reduce arterial delta pressure/delta time (dP/dt).
To prevent exacerbations of tachycardia and hypertension, treat patients with intravenous morphine sulfate. This reduces the force of cardiac contraction and the rate of rise of the aortic pressure. It then retards the propagation of the dissection and delays rupture.
Antihypertensives, Other
Class Summary
These agents are used to reduce arterial dP/dt. For acute reduction of arterial pressure, the potent vasodilator sodium nitroprusside is effective. To reduce dP/dt acutely, administer an IV beta-blocker in incremental doses until a heart rate of 60-80 beats/min is attained.
When beta-blockers are contraindicated, such as in second- or third-degree atrioventricular block, consider using calcium channel blockers. Sublingual nifedipine successfully treats refractory hypertension associated with aortic dissection.
Esmolol (Brevibloc)
Esmolol is an ultra–short-acting beta2-blocker. It is particularly useful in patients with labile arterial pressure, especially if surgery is planned, because it can be discontinued abruptly if necessary. This agent is normally used in conjunction with nitroprusside. It may be useful as a means to test beta-blocker safety and tolerance in patients with a history of obstructive pulmonary disease who are at possible risk of bronchospasm from beta-blockade. The elimination half-life of esmolol is 9 minutes.
Labetalol (Trandate)
Labetalol blocks alpha-, beta1-, and beta2-adrenergic receptor sites, decreasing blood pressure.
Propranolol (Inderal LA, InnoPran XL)
Propranolol is a class II antiarrhythmic nonselective beta-adrenergic receptor blocker. It has membrane-stabilizing activity and decreases the automaticity of contractions. Propranolol is not suitable for emergency treatment of hypertension. Do not administer propranolol IV in hypertensive emergencies.
Metoprolol (Lopressor, Toprol XL)
Metoprolol is a selective beta1-adrenergic receptor blocker that decreases the automaticity of contractions. During IV administration, carefully monitor the blood pressure, heart rate, and electrocardiogram (ECG). When considering conversion from IV to oral (PO) dosage forms, use the ratio of 1 mg IV to 2.5 mg PO metoprolol.
Nitroprusside (Nitropress)
Nitroprusside causes peripheral vasodilation by direct action on venous and arteriolar smooth muscle, thus reducing peripheral resistance. It is commonly given intravenously because of its rapid onset and short duration of action. It is easily titratable to reach the desired effect.
Nitroprusside is light sensitive; both bottle and tubing should be wrapped in aluminum foil. Before initiating nitroprusside, administer a beta-blocker to counteract the physiologic response of reflex tachycardia that occurs when nitroprusside is used alone. This physiologic response increases shear forces against the aortic wall, thus increasing dP/dt. The objective is to keep the heart rate at 60-80 bpm.
Nifedipine (Procardia)
Nifedipine is one of the more common channel blockers used for hypertension.
Analgesics
Class Summary
Pain control is essential to quality patient care. It ensures patient comfort, promotes pulmonary toilet, and prevents exacerbations of tachycardia and hypertension.
Morphine sulfate (Astramorph, Infumorph, MS Contin, Avinza)
Morphine is the drug of choice for narcotic analgesia because of its reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Like fentanyl, morphine sulfate is easily titrated to the desired level of pain control. If administered IV, morphine may be dosed in a number of ways; it is commonly titrated until the desired effect is obtained.
Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. Feb 16 2000;283(7):897-903. [Medline].
Patel PD, Arora RR. Pathophysiology, diagnosis, and management of aortic dissection. Ther Adv Cardiovasc Dis. Dec 2008;2(6):439-68. [Medline].
Isselbacher EM. Diseases of the Aorta. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, Pa: WB Saunders; 2001:1431-48.
Sutherland A, Escano J, Coon TP. D-dimer as the sole screening test for acute aortic dissection: a review of the literature. Ann Emerg Med. Oct 2008;52(4):339-43. [Medline].
Spittell PC, Spittell JA Jr, Joyce JW, et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc. Jul 1993;68(7):642-51. [Medline].
von Kodolitsch Y, Nienaber CA, Dieckmann C, et al. Chest radiography for the diagnosis of acute aortic syndrome. Am J Med. Jan 15 2004;116(2):73-7. [Medline].
Altman LK. The Man on the Table Devised the Surgery. NY Times, December 25, 2006. Available at http://www.nytimes.com/2006/12/25/health/25surgeon.html?pagewanted=1&ei=5094&en=e9f039dd9b8b2d74&hp&ex=1167109200&partner=homepage. Accessed September 27, 2011.
Spiegel EA, Wassreman S. Experimentalstudien uber die Entsehungdes Aortenschmerzes und seine Leitung zum zentralnervensystem. Ztschr F. d. ges. Exper Med. 1926;52:180-196.
Mimoun L, Detaint D, Hamroun D, et al. Dissection in Marfan syndrome: the importance of the descending aorta. Eur Heart J. Feb 2011;32(4):443-9. [Medline].
Niino T, Hata M, Sezai A, et al. Optimal clinical pathway for the patient with type B acute aortic dissection. Circ J. Feb 2009;73(2):264-8. [Medline].
Friedman WF, Silverman N. Congenital Heart Disease in Infancy and Childhood. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, Pa: WB Saunders; 2001:1546.
Clouse WD, Hallett JW Jr, Schaff HV, et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. Feb 2004;79(2):176-80. [Medline].
The Gale Encyclopedia of Medicine. 3rd ed. Stamford, Conn: Gale; 2008.
Roberts WC. Aortic dissection: anatomy, consequences, and causes. Am Heart J. Feb 1981;101(2):195-214. [Medline].
Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. Mar 1 1984;53(6):849-55. [Medline].
Suzuki T, Distante A, Zizza A, et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation. May 26 2009;119(20):2702-7. [Medline].
[Guideline] Mammen L, Yucel EK, Khan A, et al. American College of Radiology Appropriateness Criteria acute chest pain - suspected aortic dissection. 2008;[Full Text].
Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Diagnostic imaging in the evaluation of suspected aortic dissection. Old standards and new directions. N Engl J Med. Jan 7 1993;328(1):35-43. [Medline].
Czerny M, Krähenbühl E, Reineke D, et al. Mortality and neurologic injury after surgical repair with hypothermic circulatory arrest in acute and chronic proximal thoracic aortic pathology: effect of age on outcome. Circulation. Sep 27 2011;124(13):1407-13. [Medline].
Erbel R, Engberding R, Daniel W, Roelandt J, Visser C, Rennollet H. Echocardiography in diagnosis of aortic dissection. Lancet. Mar 4 1989;1(8636):457-61. [Medline].
Meredith EL, Masani ND. Echocardiography in the emergency assessment of acute aortic syndromes. Eur J Echocardiogr. Jan 2009;10(1):i31-9. [Medline].
Adachi H, Kyo S, Takamoto S, Kimura S, Yokote Y, Omoto R. Early diagnosis and surgical intervention of acute aortic dissection by transesophageal color flow mapping. Circulation. Nov 1990;82(5 Suppl):IV19-23. [Medline].
Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. Jan 7 1993;328(1):1-9. [Medline].
Nienaber CA, Spielmann RP, von Kodolitsch Y, et al. Diagnosis of thoracic aortic dissection. Magnetic resonance imaging versus transesophageal echocardiography. Circulation. Feb 1992;85(2):434-47. [Medline].
Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med. May 20 1999;340(20):1546-52. [Medline].
Glower DD, Fann JI, Speier RH, et al. Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. Circulation. Nov 1990;82(5 Suppl):IV39-46. [Medline].
Kato M, Bai H, Sato K, Kawamoto S, Kaneko M, Ueda T, et al. Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase. Circulation. Nov 1 1995;92(9 Suppl):II107-12. [Medline].
Nienaber CA, Fattori R, Lund G, et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med. May 20 1999;340(20):1539-45. [Medline].
ZZZ PLACEHOLDER.
Fann JI, Smith JA, Miller DC, et al. Surgical management of aortic dissection during a 30-year period. Circulation. Nov 1 1995;92(9 Suppl):II113-21. [Medline].
Kasirajan K, Kwolek CJ, Gupta N, Fairman RM. Incidence of and outcomes after misaligned deployment of the talent thoracic stent graft system. J Vasc Surg. May 2010;51(5):1096-101. [Medline].
Chang G, Wang H, Chen W, Yao C, Li Z, Wang S. Endovascular repair of a type B aortic dissection with a ventricular septal defect occluder. J Vasc Surg. Jun 2010;51(6):1507-9. [Medline].
Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol. Mar 2 2010;55(9):841-57. [Medline].
Parsa CJ, Schroder JN, Daneshmand MA, McCann RL, Hughes GC. Midterm results for endovascular repair of complicated acute and chronic type B aortic dissection. Ann Thorac Surg. Jan 2010;89(1):97-102; discussion 102-4. [Medline].
Berland TL, Cayne NS, Veith FJ. Access complications during endovascular aortic repair. J Cardiovasc Surg (Torino). Feb 2010;51(1):43-52. [Medline].
O'Donnell S, Geotchues A, Beavers F, Akbari C, Lowery R, Elmassry S, et al. Endovascular management of acute aortic dissections. J Vasc Surg. Nov 2011;54(5):1283-9. [Medline].
Kaya A, Heijmen RH, Rousseau H, et al. Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry). Eur J Cardiothorac Surg. Feb 2009;35(2):276-81. [Medline].
Shu C, Wang T, Li QM, Li M, Jiang XH, Luo MY, et al. Thoracic endovascular aortic repair for retrograde type A aortic dissection with an entry tear in the descending aorta. J Vasc Interv Radiol. Apr 2012;23(4):453-60, 460.e1. [Medline].
Kouchoukos NT, Dougenis D. Surgery of the thoracic aorta. N Engl J Med. Jun 26 1997;336(26):1876-88. [Medline].

